Tag: GCP compliance

Using Real Case Studies and Inspection Outcomes in GCP Courses

Posted on By digi

Using Real Case Studies and Inspection Outcomes in GCP Courses Clinical research is a complex and evolving field governed by stringent regulations and guidelines. Good Clinical Practice (GCP) serves as the international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials that involve the participation of human subjects. This article aims…

Read More “Using Real Case Studies and Inspection Outcomes in GCP Courses” »

GCP Training & Competency

Maintaining Training Records That Satisfy Inspectors and Auditors

Posted on By digi

Maintaining Training Records That Satisfy Inspectors and Auditors Maintaining Training Records That Satisfy Inspectors and Auditors In the ever-evolving landscape of clinical research, the compliance with Good Clinical Practice (GCP) training is pivotal to the success of clinical trials. The adherence to regulatory standards set forth by organizations such as the FDA, EMA, and MHRA…

Read More “Maintaining Training Records That Satisfy Inspectors and Auditors” »

GCP Training & Competency

Site-Level vs Sponsor-Level Deviation Responsibilities and Documentation

Posted on By digi

Site-Level vs Sponsor-Level Deviation Responsibilities and Documentation Site-Level vs Sponsor-Level Deviation Responsibilities and Documentation In the landscape of clinical research, deviation management is critical for ensuring compliance with regulatory standards and maintaining data integrity. This article aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a comprehensive understanding of the responsibilities related…

Read More “Site-Level vs Sponsor-Level Deviation Responsibilities and Documentation” »

Deviation/Incident Management

Escalation Pathways When Monitoring Identifies Serious Non-Compliance

Posted on By digi

Escalation Pathways When Monitoring Identifies Serious Non-Compliance In the realm of clinical research, monitoring is a critical function aimed at ensuring compliance with Good Clinical Practice (GCP) standards, regulatory requirements, and study protocols. While monitoring serves to proactively identify potential issues, the discovery of serious non-compliance requires a structured response to protect participant safety and…

Read More “Escalation Pathways When Monitoring Identifies Serious Non-Compliance” »

Monitoring Visit Planning & Follow-Up Letters

Visit Scheduling and Workload Management Across Large Site Portfolios

Posted on By digi

Visit Scheduling and Workload Management Across Large Site Portfolios Visit Scheduling and Workload Management Across Large Site Portfolios In the rapidly evolving landscape of clinical research, effective visit scheduling and workload management across large site portfolios is crucial for the success of clinical trials. This detailed guide aims to provide clinical operations, regulatory affairs, and…

Read More “Visit Scheduling and Workload Management Across Large Site Portfolios” »

Monitoring Visit Planning & Follow-Up Letters

Vendor and Partner GCP Training Requirements and Evidence

Posted on By digi

Vendor and Partner GCP Training Requirements and Evidence Vendor and Partner GCP Training Requirements and Evidence The implementation and management of clinical trials require adherence to stringent regulatory standards and Good Clinical Practice (GCP) guidelines. This tutorial aims to provide a comprehensive overview of GCP training requirements and evidence for vendors and partners involved in…

Read More “Vendor and Partner GCP Training Requirements and Evidence” »

GCP Training & Competency

Linking GCP Training Gaps to Deviations, Audit Findings and CAPA

Posted on By digi

Linking GCP Training Gaps to Deviations, Audit Findings and CAPA Good Clinical Practice (GCP) compliance is essential in clinical trials, particularly when addressing complex conditions like Crohn’s disease and ulcerative colitis. This tutorial offers a step-by-step guide aimed at clinical operations, regulatory affairs, and medical affairs professionals. It focuses on identifying GCP training gaps that…

Read More “Linking GCP Training Gaps to Deviations, Audit Findings and CAPA” »

GCP Training & Competency

Using Deviation Trends to Identify Systemic Clinical Quality Issues

Posted on By digi

Using Deviation Trends to Identify Systemic Clinical Quality Issues Using Deviation Trends to Identify Systemic Clinical Quality Issues Clinical trials are complex undertakings that require meticulous oversight to ensure compliance with governed practices and to safeguard participant welfare. One critical component of effective clinical trial management is identifying and addressing deviations that may occur throughout…

Read More “Using Deviation Trends to Identify Systemic Clinical Quality Issues” »

Deviation/Incident Management

Leveraging Centralized Monitoring to Target On-Site Activities

Posted on By digi

Leveraging Centralized Monitoring to Target On-Site Activities Leveraging Centralized Monitoring to Target On-Site Activities In the current landscape of clinical trials, the need for effective monitoring strategies has never been greater. Centralized monitoring has emerged as a pivotal component in enhancing the efficiency and accuracy of clinical trial oversight. This tutorial aims to provide a…

Read More “Leveraging Centralized Monitoring to Target On-Site Activities” »

Monitoring Visit Planning & Follow-Up Letters

Tracking Action Items From Monitoring Visits to Closure

Posted on By digi

Tracking Action Items From Monitoring Visits to Closure Tracking Action Items From Monitoring Visits to Closure Effective management of clinical trials requires meticulous attention to detail, especially during monitoring visits. Following these visits, it is critical to track action items until closure, ensuring compliance with ICH-GCP guidelines and regulatory requirements from authorities such as the…

Read More “Tracking Action Items From Monitoring Visits to Closure” »

Monitoring Visit Planning & Follow-Up Letters